Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer, Stage IIIb or IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01000025
What this trial is testing

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 720
Testing effectiveness (Phase 2)UnknownNCT00006215
What this trial is testing

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Amgen
Early research (Phase 1)Study completedNCT01302808
What this trial is testing

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
University of Texas Southwestern Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT00651508
What this trial is testing

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 1
Testing effectiveness (Phase 2)Study completedNCT00198393
What this trial is testing

Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 126
Testing effectiveness (Phase 2)Ended earlyNCT00145418
What this trial is testing

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Oncology Specialists, S.C. 15
Testing effectiveness (Phase 2)Ended earlyNCT00760929
What this trial is testing

The Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 171
Testing effectiveness (Phase 2)Study completedNCT00005865
What this trial is testing

Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00072059
What this trial is testing

Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
AnemiaLung Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04929041
What this trial is testing

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Non-Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 427
Testing effectiveness (Phase 2)WithdrawnNCT02355431
What this trial is testing

Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Who this might be right for
Solid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation
Large-scale testing (Phase 3)UnknownNCT03952403
What this trial is testing

HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung
Shanghai Henlius Biotech 643
Post-approval studies (Phase 4)Study completedNCT00686322
What this trial is testing

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Non-small-cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 6
Large-scale testing (Phase 3)Study completedNCT00252707
What this trial is testing

Iressa 2nd Line Phase III Study in Japan

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 484
Not applicableStudy completedNCT00898820
What this trial is testing

Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524

Who this might be right for
Lung Cancer
Mayo Clinic 80
Testing effectiveness (Phase 2)Study completedNCT00004096
What this trial is testing

Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00062062
What this trial is testing

Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Large-scale testing (Phase 3)Not Yet RecruitingNCT07829549
What this trial is testing

Phase III Study of RC148 Plus Chemotherapy Versus Tislelizumab Plus Chemotherapy as First-Line Treatment for Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Who this might be right for
Previously Untreated Locally Advanced (IIIB/IIIC) or Metastatic (IV) e Nsq NSCLC Without Actionable Genomic Alterations
RemeGen Co., Ltd. 540
Large-scale testing (Phase 3)Study completedNCT00795340
What this trial is testing

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 306
Next Page